Arena Pharmaceuticals Interest Expense 2011-2026 | ARNA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Arena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.16 M	4.52 M	4.79 M	5.7 M	6.12 M	6.51 M	6.83 M	6.92 M	7.09 M	9.12 M	14.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.3 M	4.16 M	6.91 M

Quarterly Interest Expense Arena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	1.03 M	1.05 M	1.07 M	-	1.12 M	1.14 M	1.16 M	-	1.2 M	1.22 M	1.24 M	-	1.42 M	1.45 M	1.47 M	-	1.52 M	1.54 M	1.57 M	-	1.61 M	1.62 M	1.68 M	-	1.68 M	1.75 M	1.7 M	-	1.72 M	1.74 M	1.75 M	-	1.77 M	1.78 M	1.79 M	-	1.8 M	2.49 M	3.03 M	-	3.21 M	3.18 M	4.69 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.69 M	1.03 M	1.76 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Agenus AGEN	1.26 M	$ 3.27	-1.8 %	$ 1.17 M	USA
Agios Pharmaceuticals AGIO	1.96 M	$ 29.33	-2.98 %	$ 1.7 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Akebia Therapeutics AKBA	58 K	$ 1.26	-3.44 %	$ 324 M	USA
Akari Therapeutics, Plc AKTX	-3 K	$ 0.24	1.1 %	$ 5.73 B	Britain
Aldeyra Therapeutics ALDX	1.69 M	$ 5.49	0.52 %	$ 330 M	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Alector ALEC	13.2 M	$ 2.26	-7.2 %	$ 233 M	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Aligos Therapeutics ALGS	4.3 M	$ 7.02	-0.21 %	$ 451 M	USA
Alkermes plc ALKS	4.47 M	$ 29.32	-2.61 %	$ 4.83 B	Irlanda
Allogene Therapeutics ALLO	-17.8 M	$ 2.57	-7.73 %	$ 403 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Alnylam Pharmaceuticals ALNY	5.2 M	$ 330.95	-0.59 %	$ 43.4 B	USA
Altimmune ALT	48 K	$ 4.2	-2.55 %	$ 298 M	USA
ALX Oncology Holdings ALXO	1.73 M	$ 2.11	0.09 %	$ 110 M	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 20.22	-0.05 %	$ 945 M	USA
Amarin Corporation plc AMRN	8 K	$ 13.62	-1.3 %	$ 5.55 B	Irlanda
AIM ImmunoTech AIM	629 K	$ 0.92	5.25 %	$ 44.2 M	USA
AnaptysBio ANAB	14 K	$ 54.61	-0.8 %	$ 1.55 B	USA
ANI Pharmaceuticals ANIP	-4.03 M	$ 75.31	1.91 %	$ 1.45 B	USA
Annexon ANNX	57 K	$ 5.38	-3.93 %	$ 739 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Apellis Pharmaceuticals APLS	-133 K	$ 20.53	-2.05 %	$ 2.59 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Aprea Therapeutics APRE	1.19 M	$ 0.88	-3.71 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	472 K	$ 7.28	-0.55 %	$ 2.01 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aquestive Therapeutics AQST	6.55 M	$ 3.99	-0.15 %	$ 346 M	USA
Arcturus Therapeutics Holdings ARCT	15.2 M	$ 8.11	-1.44 %	$ 219 M	Israel
Ardelyx ARDX	4.5 M	$ 6.32	-3.54 %	$ 1.52 B	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA